期刊文献+

多西环素对心肌梗死后心功能的保护作用

Protection of doxycycline on cardiac function after myocardial infarction in rats
原文传递
导出
摘要 目的:采用超声心动图观察大鼠心肌梗死(MI)模型中外源性基质金属蛋白酶抑制剂多西环素对左心室功能的保护作用。方法:通过结扎SD大鼠冠状动脉前降支建立MI模型。分为MI组(15只)、治疗组(16只),分别于术后即刻、术后2周、术后4周采用Acuson Sequoia 512超声心动图机分别测定左室前壁、后壁厚度以及左心室舒张末期内径和左室射血分数。结果:左室重量4周时治疗组比MI组轻(P<0.05);左室前壁厚度4周时治疗组大于MI组(P<0.05);左室舒张末期内径4周时MI组大于治疗组(P<0.05)。结论:经多西环素治疗后的MI SD大鼠,心功能得以改善,其机制与MI后外源性基质金属蛋白酶抑制剂参与心室重塑有关。 Objective:Protection of doxycycline(extragenous inhibitor of matrix metalloproteinases) on cardiac function was observed following myocardial infarction in rats by echocardiography. Method: The descending left coronary artery of male rats (Sprague-dawley) was ligated to produce a myocardial infarction model. Thirty-one rats were randomly divided into two groups: myocardial infarction (Group MI, n =15) and doxycycline (Group D, n = 16). The thickness of left ventricular wall, the diastolic diameter of left ventrieular and EF were measured by echocardiography (Acuson Sequoia 512) on the 2nd and 4th week. Result:The weight of left ventricle in group D was lighter than that in group MI ( P 〈0.05) : The thickness of anterior wall in group D was larger than that in group MI ( P 〈0.05); LVDd in group MI was larger than that in group D( P 〈0.05). Conclusion:Doxycycline can improve the cardiac function following myocardial infarction. The mechanism may be interrelated with extragenous inhibitor of matrix metalloproteinases participation in ventricular remodeling.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第12期713-715,共3页 Journal of Clinical Cardiology
关键词 心肌梗死 基质金属蛋白酶抑制剂 超声心动描记术 Myocardial infarction Inhibitor of matrix metalloproteinases Echocardiography
  • 相关文献

参考文献8

  • 1Hiroyuki T,Hiroshi H,Toshio N,et al.Implication of cardiac remodeling in heart failure:mechanisms and therapeutic strategies.Int Med,2003,42:465-469.
  • 2郭建中,高长青.基质金属蛋白酶在大鼠心肌梗死模型心室重塑中的作用[J].临床心血管病杂志,2005,21(6):364-366. 被引量:7
  • 3Thomas P,Li H,Lisa D,et al.Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infracted rat.Cardiovasc Res,2000,46:307-315.
  • 4Thomas P,Hussein H,Linda J,et al.Matrix metallo proteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.Circulation,2001,103:2303-2309.
  • 5White H D,Norris R M,Brown M A,et al.Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation,1987,76:44-51.
  • 6Spinale F G.Matrix Metalloproteinases regulation and dysregulation in the failing heart.Circ Res,2002,90:520-530.
  • 7Francisco J,Michael G,Jeffrey O,et al.Early shortterm treatment with doxycycline modulates postinfarction left ventricular remodeling.Circulation,2003,108:1487-1492.
  • 8Steffen L,Simon H.S,Karl T W.Doxycycline and tissue repair in rats.J Lab Clin Med,2002,139:295-302.

二级参考文献6

  • 1Takano H, Hasegawa H, Nagai T,et al. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies. Internal Med, 2003, 42: 465-469.
  • 2Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, Function and Biochemistry. Circ Res,2003, 92: 827-839.
  • 3Ikeda U, Shimada K. Matrix metalloproteinases and coronary artery diseases. Clin Cardiol,2003, 26: 55-59.
  • 4Chapman R E, Scott A A, Deschamps A M, et al. Matrix metalloproteinase abundance in human myocardial fibroblasts: effects of sustained pharmacologic matrix metalloproteinase inhibition. J Mol Cell Cardiol,2003,35: 539-548.
  • 5Creemers E E, Cleutjens J P, Smits J F,et al. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? Circ Res,2001, 89: 201-210.
  • 6Nishikawa N,Yamamoto K, Sakata Y, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res.2003,57: 766-774.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部